Clinical utility and prospective of TMS–EEG: Updated review from an international expert group
Hertie Institute for Clinical Brain Research · University of Tübingen · +52 more institutions
Abstract
Transcranial magnetic stimulation (TMS) is a non-invasive technique to stimulate the brain, while electroencephalography (EEG) is a non-invasive technique to record its electrical activity. Their combined use (TMS-EEG) has been established only relatively recently, after successful development of TMS-compatible EEG amplifiers. TMS-EEG offers the unparalleled opportunity to directly perturb the brain with TMS and simultaneously record its response with EEG. This allows inferences on causal input-output relationships, therefore going critically beyond purely observational techniques, such as resting-state EEG or functional MRI, in the study of brain dynamics. This consensus review updates the work of Tremblay…
Citation impact
- FWCI
- 127.75
- Percentile
- 100%
- References
- 721
Authors
62- UZUlf ZiemannCorresponding
Hertie Institute for Clinical Brain Research, University of Tübingen
- YBYang Bai
First Affiliated Hospital of Jiangxi Medical College
- FMFiona M. Baumer
Neurosciences Institute, Stanford University
- MMMikkel M. Beck
Hvidovre Hospital
- PBPaolo Belardinelli
University of Trento, Hertie Institute for Clinical Brain Research
Topics & keywords
- Electroencephalography
- Transcranial magnetic stimulation
- Clinical neurophysiology
- Observational study
- Neurophysiology
- Brain stimulation
Funding
- WFWatanabe Foundation
- BWBurroughs Wellcome FundAward: ERC-2022-SYG - 101071900
- DDDoris Duke Charitable Foundation
- BABrain and Behavior Research FoundationAward: 31954
- OBOntario Brain Institute
- JAJapan Agency for Medical Research and Development
- CFCentre for Addiction and Mental Health
- OROntario Research Foundation
- IInnovationsfondenAward: 9068-00025B
- EJEU Joint Programme – Neurodegenerative Disease ResearchAward: 10510062210003
- IRInter Reha
- CFCanada Foundation for InnovationAward: 43911
- MSMichael Smith Health Research BCAward: 17727
- ECEuropean Commission
- DFDeutsche ForschungsgemeinschaftAwards: ZI 542/13-1, 456732630, RTG 2783, 431549029 \u2013 SFB 1451
- ANAgence Nationale de la RechercheAward: ANR-25-CE37-2363
- MOMinistry of Education, Culture, Sports, Science and Technology
- NNNational Natural Science Foundation of ChinaAwards: 82560454, 82472605
- ZZonMwAward: 114025101
- MDMinistero dell’Istruzione, dell’Università e della Ricerca
- LLundbeckfonden
- UOUniversity of Toronto
- ISIsrael Science FoundationAward: 2278/22
- KYKuopion Yliopistollinen SairaalaAwards: 5041830, 5041742
- EEpilepsiefondsAward: 2022-10
- UJUniversitätsklinikum JenaAwards: ME 5820/4-1, 24K10740, 101059369, 20222ZLPFC, 21H02813
- NNNovo Nordisk Fonden
- TPTeijin Pharma
- MUMarga und Walter Boll-StiftungAwards: 1188607, 468645090
- TFTemerty Family Foundation
- NINational Institutes of HealthAwards: R01MH132074, R01MH139650, R01MH126639, K12TR004788
- H2Horizon 2020 Framework Programme
- CICanadian Institutes of Health ResearchAward: 165863
- NSNatural Sciences and Engineering Research Council of CanadaAward: RGPIN-2015-05783
- FDFonds de Recherche du Québec - SantéAward: 309921
- EREuropean Research CouncilAwards: ZI 542/13-1, 810377
- ARAustralian Research CouncilAward: FT210100694
- NHNational Health and Medical Research CouncilAward: 1193596
- JSJapan Society for the Promotion of Science
- NINational Institute on AgingAward: P01AG031720
- NINational Institute of Mental Health
- NINational Institute of Neurological Disorders and StrokeAward: K23NS116110
- NCNational Center for Advancing Translational Sciences
- SMStanford Maternal and Child Health Research Institute